Altair International Corp. Files 10-Q for Period Ending December 31, 2023
Ticker: PREM · Form: 10-Q · Filed: Feb 14, 2024 · CIK: 1570937
Sentiment: neutral
Topics: 10-Q, Altair International Corp., Financial Report, SEC Filing, Q3 2024
TL;DR
<b>Altair International Corp. has filed its Q3 2024 10-Q report, detailing financial performance up to December 31, 2023.</b>
AI Summary
ALTAIR INTERNATIONAL CORP. (PREM) filed a Quarterly Report (10-Q) with the SEC on February 14, 2024. Altair International Corp. filed its 10-Q report for the period ending December 31, 2023. The filing covers the third quarter of fiscal year 2024. The company's fiscal year ends on March 31st. Altair International Corp. is incorporated in Nevada. The company's business address is in Pittsburgh, PA.
Why It Matters
For investors and stakeholders tracking ALTAIR INTERNATIONAL CORP., this filing contains several important signals. This 10-Q filing provides investors with the latest financial data and operational updates for Altair International Corp., crucial for assessing the company's performance and future prospects. Understanding the details within this report allows stakeholders to make informed investment decisions based on the company's financial health and strategic direction.
Risk Assessment
Risk Level: low — ALTAIR INTERNATIONAL CORP. shows low risk based on this filing. The filing is a standard 10-Q, providing routine financial disclosures without immediate red flags, indicating a low level of immediate risk from this specific document.
Analyst Insight
Review the detailed financial statements and management's discussion and analysis within the 10-Q to identify any emerging trends or significant changes in Altair International Corp.'s performance.
Key Numbers
- 20231231 — Reporting Period End Date (Conformed period of report)
- 20240214 — Filing Date (Filed as of date)
- Q3 2024 — Quarter (Indicates the filing is for the third quarter of the fiscal year)
- 0331 — Fiscal Year End (Company's fiscal year end month and day)
Key Players & Entities
- ALTAIR INTERNATIONAL CORP. (company) — Filer name
- 20231231 (date) — Conformed period of report
- 20240214 (date) — Filed as of date
- 3841 (other) — Standard Industrial Classification (SIC) code for Surgical & Medical Instruments & Apparatus
- NV (other) — State of incorporation
- PITTSBURGH (location) — Business and mailing city
- PA (location) — Business and mailing state
- 412-770-3140 (phone) — Business phone number
FAQ
When did ALTAIR INTERNATIONAL CORP. file this 10-Q?
ALTAIR INTERNATIONAL CORP. filed this Quarterly Report (10-Q) with the SEC on February 14, 2024.
What is a 10-Q filing?
A 10-Q is a quarterly financial report with unaudited financials, management discussion, and interim business updates. This particular 10-Q was filed by ALTAIR INTERNATIONAL CORP. (PREM).
Where can I read the original 10-Q filing from ALTAIR INTERNATIONAL CORP.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by ALTAIR INTERNATIONAL CORP..
What are the key takeaways from ALTAIR INTERNATIONAL CORP.'s 10-Q?
ALTAIR INTERNATIONAL CORP. filed this 10-Q on February 14, 2024. Key takeaways: Altair International Corp. filed its 10-Q report for the period ending December 31, 2023.. The filing covers the third quarter of fiscal year 2024.. The company's fiscal year ends on March 31st..
Is ALTAIR INTERNATIONAL CORP. a risky investment based on this filing?
Based on this 10-Q, ALTAIR INTERNATIONAL CORP. presents a relatively low-risk profile. The filing is a standard 10-Q, providing routine financial disclosures without immediate red flags, indicating a low level of immediate risk from this specific document.
What should investors do after reading ALTAIR INTERNATIONAL CORP.'s 10-Q?
Review the detailed financial statements and management's discussion and analysis within the 10-Q to identify any emerging trends or significant changes in Altair International Corp.'s performance. The overall sentiment from this filing is neutral.
How does ALTAIR INTERNATIONAL CORP. compare to its industry peers?
Altair International Corp. operates within the Surgical & Medical Instruments & Apparatus industry (SIC 3841). This 10-Q filing provides insights into its performance within this sector.
Are there regulatory concerns for ALTAIR INTERNATIONAL CORP.?
As a publicly traded company, Altair International Corp. is subject to SEC regulations, including the requirement to file quarterly reports (10-Q) to ensure transparency and provide timely financial information to investors.
Industry Context
Altair International Corp. operates within the Surgical & Medical Instruments & Apparatus industry (SIC 3841). This 10-Q filing provides insights into its performance within this sector.
Regulatory Implications
As a publicly traded company, Altair International Corp. is subject to SEC regulations, including the requirement to file quarterly reports (10-Q) to ensure transparency and provide timely financial information to investors.
What Investors Should Do
- Analyze the financial statements for revenue, net income, and cash flow trends.
- Examine the Management's Discussion and Analysis (MD&A) section for insights into business performance and outlook.
- Review any disclosed risk factors or legal proceedings for potential impacts on the company.
Year-Over-Year Comparison
This is the initial analysis of the 10-Q filing for the period ending December 31, 2023. Comparative data from previous filings would be needed for a full 'vs last filing' analysis.
Filing Stats: 4,670 words · 19 min read · ~16 pages · Grade level 14 · Accepted 2024-02-14 16:30:45
Key Financial Figures
- $0.001 — e 30,075,352 shares of the registrant's $0.001 par value common stock issued and outst
- $17,710 — notes payable, net of debt discount of $17,710 and $129,180, respectively 180,517 47
- $129,180 — le, net of debt discount of $17,710 and $129,180, respectively 180,517 47,844 Deriva
- $8,000,000 — revenue on all payments in excess of US $8,000,000 of production on an annualized basis.
- $0.02 — agreed to change the conversion rate to $0.02. (2) Converts at $0.015 per share.
- $0.015 — rsion rate to $0.02. (2) Converts at $0.015 per share. A summary of the activity
- $8,217 — 5, 2023, EROP Enterprises LLC converted $8,217 and $623, of principal and interest, re
- $623 — OP Enterprises LLC converted $8,217 and $623, of principal and interest, respectivel
- $25,000 — On January 29, 2024, Thirty05 converted $25,000 and $2,772 of principal and interest, r
- $2,772 — 9, 2024, Thirty05 converted $25,000 and $2,772 of principal and interest, respectively
- $11,783 — k. On February 5, 2024, EROP converted $11,783 and $997 of principal and interest, res
- $997 — ary 5, 2024, EROP converted $11,783 and $997 of principal and interest, respectively
- $75,000 — ich we agreed to make total payments of $75,000 to AMLM in exchange for a 10% undivided
- $30,000 — as been fully satisfied by the Company ($30,000 paid 12/8/2020 and $45,000 paid 1/5/202
- $45,000 — the Company ($30,000 paid 12/8/2020 and $45,000 paid 1/5/2021), resulting in Altair own
Filing Documents
- atao0214form10q.htm (10-Q) — 574KB
- atao0214form10qexh31_1.htm (EX-31.1) — 9KB
- atao0214form10qexh32_1.htm (EX-32.1) — 4KB
- 0001554795-24-000012.txt ( ) — 3019KB
- atao-20231231.xsd (EX-101.SCH) — 28KB
- atao-20231231_cal.xml (EX-101.CAL) — 27KB
- atao-20231231_def.xml (EX-101.DEF) — 61KB
- atao-20231231_lab.xml (EX-101.LAB) — 186KB
- atao-20231231_pre.xml (EX-101.PRE) — 142KB
- atao0214form10q_htm.xml (XML) — 514KB
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION Item 1. Unaudited Financial Statements 3 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 13 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 15 Item 4.
Controls and Procedures
Controls and Procedures 15
- OTHER INFORMATION
PART II - OTHER INFORMATION Item 1.
Legal Proceedings
Legal Proceedings 17 Item1A.
Risk Factors
Risk Factors 17 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 17 Item 3. Defaults Upon Senior Securities 17 Item 4. Mine Safety Disclosures 17 Item 5. Other Information 17 Item 6. Exhibits 17
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION
UNAUDITED FINANCIAL STATEMENTS
ITEM 1. UNAUDITED FINANCIAL STATEMENTS ALTAIR INTERNATIONAL CORP. INDEX TO FINANCIAL STATEMENTS Consolidated Balance Sheets as of December 31, 2023 (unaudited) and March 31, 2023 4 Consolidated Statements of Operations for the Three and Nine Months ended December 31, 2023 and 2022 (unaudited) 5 Consolidated Statement of Stockholders' Equity (Deficit) for the Three and Nine Months ended December 31, 2023 and 2022 (unaudited) 6 Consolidated Statements of Cash Flows for the Nine Months ended December 31, 2023 and 2022 (unaudited) 7 Notes to the Unaudited Consolidated Financial Statements 8 3 ALTAIR INTERNATIONAL CORP. CONSOLIDATED BALANCE SHEETS December 31, 2023 March 31, 2023 ASSETS (unaudited) Current Assets: Cash $ 12,594 $ 28,897 Prepaid 3,990 — Prepaid stock compensation — 7,980 Total Current Assets 16,584 36,877 Total Assets $ 16,584 $ 36,877 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Current Liabilities: Accounts payable $ 3,500 $ 3,500 Accrued compensation 62,000 25,500 Loans payable 14,165 14,165 Interest payable 14,630 3,889 Due to a related party 4,000 — Convertible notes payable, net of debt discount of $17,710 and $129,180, respectively 180,517 47,844 Derivative liability — 88,169 Total Current Liabilities 278,812 183,067 Total Liabilities 278,812 183,067 Stockholders' Equity (Deficit): Preferred Stock, $ 0.001 par value, 10,000,000 shares authorized, no shares issued — — Common Stock, $ 0.001 par value, 5,000,000,000 shares authorized; 25,692,459 and 24,692,459 shares issued and outstanding, respectively 25,018 24,693 Additional paid in capital 16,954,157 16,945,642 Accumulated deficit ( 17,241,403 ) ( 17,116,525 ) Total Stockholders' Equity (Deficit) ( 262,228 ) ( 146,190 ) Total Liabilities and Stockholders' Deficit $ 16,584 $ 36,877 The accompanying notes are an integral part of these unaudited consolidated financial statement
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION OR PLAN OF OPERATION
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION OR PLAN OF OPERATION
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These forward-looking statements are not historical facts but rather are based on current expectations, estimates and projections. We may use words such as "anticipate," "expect," "intend," "plan," "believe," "foresee," "estimate" and variations of these words and similar expressions to identify forward-looking statements. These statements are not guarantees of future performance and are actual results to differ materially from those expressed or forecasted. You should read this report completely and with the understanding that actual future results may be materially different from what we expect. The forward-looking statements included in this report are made as of the date of this report and should be evaluated with consideration of any changes occurring after the date of this Report. We will not update forward-looking statements even though our situation may change in the future and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Our Business Altair International Corp. ("Altair") is a development stage company that was incorporated in Nevada on December 20, 2012. The Company is currently in very preliminary discussions with a number of acquisition targets, each of which we believe would deliver significant value to our shareholders. The Company is currently engaged in identifying and assessing new business opportunities. Earn-In Agreement On November 23, 2020, the Company entered into an Earn-In Agreement with American Lithium Minerals, Inc. ("AMLM") un